Swiss (SMI) Life Sciences Industry Analysis

Industry Valuation and Performance

Has the Swiss Life Sciences Industry valuation changed over the past few years?

Date	Market Cap	Revenue	Earnings	PE	Absolute PE	PS
Wed, 22 Mar 2023	CHF56.4b	CHF9.7b	CHF1.7b	41.5x	34x	5.8x
Fri, 17 Feb 2023	CHF58.0b	CHF9.6b	CHF1.6b	33.9x	35.5x	6.1x
Sun, 15 Jan 2023	CHF53.4b	CHF9.2b	CHF1.3b	40x	40.2x	5.8x
Tue, 13 Dec 2022	CHF51.3b	CHF9.2b	CHF1.3b	37.8x	38.6x	5.6x
Thu, 10 Nov 2022	CHF54.6b	CHF9.2b	CHF1.3b	42.1x	41.1x	5.9x
Sat, 08 Oct 2022	CHF51.4b	CHF9.2b	CHF1.3b	40.7x	39.8x	5.6x
Mon, 05 Sep 2022	CHF54.4b	CHF9.2b	CHF1.3b	42.5x	42.1x	5.9x
Wed, 03 Aug 2022	CHF57.6b	CHF8.9b	CHF1.3b	35.1x	43.9x	6.5x
Fri, 01 Jul 2022	CHF52.3b	CHF8.5b	CHF1.1b	42.7x	48.5x	6.2x
Sun, 29 May 2022	CHF58.5b	CHF8.5b	CHF1.1b	47.4x	54.2x	6.9x
Tue, 26 Apr 2022	CHF61.9b	CHF8.5b	CHF1.1b	56.6x	57.4x	7.3x
Thu, 24 Mar 2022	CHF68.1b	CHF8.3b	CHF1.1b	50.6x	63.1x	8.2x
Sat, 19 Feb 2022	CHF63.8b	CHF8.0b	CHF1.1b	50x	59.7x	8x
Mon, 17 Jan 2022	CHF69.6b	CHF7.4b	CHF929.4m	72.6x	74.9x	9.4x
Wed, 15 Dec 2021	CHF77.3b	CHF7.4b	CHF918.2m	85.4x	84.2x	10.5x
Fri, 12 Nov 2021	CHF78.6b	CHF7.4b	CHF918.9m	71.3x	85.5x	10.7x
Sun, 10 Oct 2021	CHF75.4b	CHF7.4b	CHF919.7m	70.3x	82x	10.2x
Tue, 07 Sep 2021	CHF82.7b	CHF7.4b	CHF920.8m	87.5x	89.9x	11.2x
Thu, 05 Aug 2021	CHF75.4b	CHF7.4b	CHF920.8m	61.8x	81.9x	10.2x
Sun, 09 May 2021	CHF61.1b	CHF7.1b	CHF964.3m	60.5x	63.4x	8.7x
Wed, 10 Feb 2021	CHF55.2b	CHF6.5b	CHF972.6m	53.9x	56.7x	8.5x
Tue, 03 Nov 2020	CHF54.0b	CHF5.4b	CHF913.9m	57.3x	59.1x	10x
Fri, 07 Aug 2020	CHF52.6b	CHF5.3b	CHF889.3m	56.1x	59.2x	9.9x
Thu, 30 Apr 2020	CHF40.0b	CHF5.6b	CHF858.4m	47x	46.6x	7.1x

Current Industry PE

Investors are pessimistic on the Swiss Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.

The industry is trading at a PE ratio of 34.0x which is lower than its 3-year average PE of 58.1x.

The 3-year average PS ratio of 8.2x is higher than the industry's current PS ratio of 5.8x.

Past Earnings Growth

The earnings for companies in the Life Sciences industry have grown 25% per year over the last three years.
Revenues for these companies have grown 20% per year.
This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Swiss Healthcare industry?


CH Market	0.63%
Healthcare	0.82%
Life Sciences	1.83%
Clinical Research and Equipment	1.83%

Industry PEThere are no additional sub-industries under this industry.

Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

Company	Last Price	7D	1Y	Valuation
LONN Lonza Group	CHF536.20	2.6% +CHF994.1m	-19.1%	PE32.7x
TECN Tecan Group	CHF394.80	2.3% +CHF112.1m	12.9%	PE41.5x
SKAN SKAN Group	CHF69.50	6.6% +CHF96.7m	8.6%	PE232.5x
SFZN Siegfried Holding	CHF649.50	0.7% +CHF42.3m	-11.2%	PE17.6x
XLS Xlife Sciences	CHF33.50	2.4% +CHF4.3m	-21.5%	PE3.7x

Mar 18

Industry Valuation and Performance